2m 2m 2m 2m 2m 2m 2m
Repligen (RGEN)
NASDAQ
$126.37-$0.20 (-0.16%)
Price as of Jun 23, 2026 4:13 PM EDT- $7.1BMarket Cap
- 5.38%1-Year Change
- Medical Instruments & SuppliesIndustry
Repligen (RGEN)
$126.37-$0.20 (-0.16%)
RGEN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $126.57 | ||
Change | -$5.45 (-4.13%) | ||
Open | $131.13 | ||
High | $133.74 | ||
Low | $125.44 | ||
Previous Close | $132.02 | ||
Volume | 865,916 | ||
30-Day Average Volume | 978,978 | ||
1-Week Change | -3.29% | ||
1-Month Change | 10.00% | ||
1-Year Change | 5.38% | ||
3-Year Change | -15.50% | ||
5-Year Change | -35.80% | ||
Fundamentals | |||
Shares Outstanding | 56.4M | ||
Total Assets | $2.9B | ||
Market Cap | $7.1B | ||
Enterprise Value | $7.1B | ||
Period: QTR TTM FY | |||
Revenue | $194.2M | ||
Net Income | $8.3M | ||
Free Cash Flow | $23.6M | ||
EBIT | $7.6M | ||
EBITDA | $27.4M | ||
Net Working Capital | $1.0B | ||
EPS | $0.15 | ||
Enterprise Value/EBITDA | 259 | ||
Enterprise Value/Revenue | 37 | ||
P/B | 3 | ||
P/E | 844 | ||
PEG | -8 | ||
Price/Free Cash Flow | 303 | ||
Price/Operating Cash Flow | 252 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue